on TRANSGENE (EPA:TNG)
Temporary suspension of trading in Transgene shares
Transgene, a biotechnology company, has announced the temporary suspension of trading in its shares on Euronext Paris. The decision, effective November 26, 2025, follows a request from the company pending the results of a capital increase. Trading is scheduled to resume on November 27, 2025, at the market opening.
The temporary suspension aims to manage the situation related to the announcement of the capital increase and to prevent any resulting market fluctuations. Transgene expects this initiative to improve its financing capacity, while keeping investors and analysts informed about the progress of this strategic operation.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all TRANSGENE news